These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2990960)

  • 1. The central vs. peripheral effects of clonidine on ACTH, corticosterone and glucose release.
    Smythe GA; Bradshaw JE; Gleeson RM; Grunstein HS; Nicholson MV
    Eur J Pharmacol; 1985 May; 111(3):401-3. PubMed ID: 2990960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACTH and corticosterone secretion following 2-deoxyglucose administration in intact and in hypothalamic deafferentated male rats.
    Weidenfeld J; Siegel RA; Corcos AP; Heled V; Conforti N; Chowers I
    Brain Res; 1984 Jul; 305(1):109-13. PubMed ID: 6331594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in responsiveness of the hypothalamic-pituitary-adrenocortical axis to 2-deoxy-D-glucose in developing rats.
    Widmaier EP
    Endocrinology; 1990 Jun; 126(6):3116-23. PubMed ID: 2161749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of the hypothalamic-pituitary-adrenal axis and inhibition of growth hormone release via increased central noradrenaline neuronal activity by urethane anaesthesia in the rat: blockade by clonidine.
    Smythe GA; Gleeson RM; Stead BH
    Aust J Biol Sci; 1987; 40(1):91-6. PubMed ID: 3274655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine-beta-hydroxylase inhibition acutely stimulates rats hypothalamic noradrenaline and dopamine neuronal activity as assessed from metabolic ratios and circulating glucose and ACTH responses.
    Smythe GA; Bradshaw JE; Gleeson RM; Nicholson MV
    Life Sci; 1985 Sep; 37(9):841-7. PubMed ID: 2993777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for central postsynaptic alpha 2-adrenoceptors in glucoregulation.
    Smythe GA; Edwards SR
    Brain Res; 1991 Oct; 562(2):225-9. PubMed ID: 1663413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic monoamine control of stress-induced adrenocorticotropin release in the rat.
    Smythe GA; Bradshaw JE; Vining RF
    Endocrinology; 1983 Sep; 113(3):1062-71. PubMed ID: 6307661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central suppressive effect of octreotide on the hyperglycemic response to 2-deoxy-D-glucose injection or cold-swim stress in awake rats: possible mediation role of hypothalamic noradrenergic drive.
    Gotoh M; Iguchi A; Kakumu S; Hirooka Y; Smythe GA
    Brain Res; 2001 Mar; 895(1-2):146-52. PubMed ID: 11259771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An exploration of the aversive properties of 2-deoxy-D-glucose in rats.
    Horman T; Fernandes MF; Zhou Y; Fuller B; Tigert M; Leri F
    Psychopharmacology (Berl); 2018 Oct; 235(10):3055-3063. PubMed ID: 30112578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal demedullation blocks and brain norepinephrine depletion potentiates the hyperglycemic response to a variety of stressors.
    Bialik RJ; Smythe JW; Sardelis M; Roberts DC
    Brain Res; 1989 Nov; 502(1):88-98. PubMed ID: 2819460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of 5-hydroxy-L-tryptophan-induced adrenocorticotropin release: a major role for central noradrenergic drive.
    Smythe GA; Gleeson RM; Stead BM
    Neuroendocrinology; 1988 May; 47(5):389-97. PubMed ID: 2840594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central histaminergic mechanisms in the corticosterone response to clonidine.
    Bugajski J; Gadek-Michalska A; Borycz J; Bugajski AJ
    J Physiol Pharmacol; 1993 Sep; 44(3):303-12. PubMed ID: 8241531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of nitric oxide formation impairs adrenergic-induced ACTH and corticosterone secretion.
    Bugajski J; Gadek-Michalska A; Głód R; Borycz J; Bugajski AJ
    J Physiol Pharmacol; 1999 Jun; 50(2):327-34. PubMed ID: 10424727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between brain noradrenergic activity and blood glucose.
    Smythe GA; Grunstein HS; Bradshaw JE; Nicholson MV; Compton PJ
    Nature; 1984 Mar 1-7; 308(5954):65-7. PubMed ID: 6322003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.
    Hadley AJ; Kumari M; Cover PO; Osborne J; Poyser R; Flack JD; Buckingham JC
    Br J Pharmacol; 1996 Oct; 119(3):463-70. PubMed ID: 8894165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the 2-deoxyglucose effect on the adrenocortical axis.
    Weidenfeld J; Corcos AP; Wohlman A; Feldman S
    Endocrinology; 1994 Apr; 134(4):1924-31. PubMed ID: 8137760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships among the behavioral, noradrenergic, and pituitary-adrenal responses to interleukin-1 and the effects of indomethacin.
    Wieczorek M; Dunn AJ
    Brain Behav Immun; 2006 Sep; 20(5):477-87. PubMed ID: 16330180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamus, anterior pituitary and adrenal gland involvement in the activation of adrenocorticotropin and corticosterone secretion by gastrin-releasing peptide.
    Garrido MM; Manzanares J; Fuentes JA
    Brain Res; 1999 May; 828(1-2):20-6. PubMed ID: 10320721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intracerebroventricular clonidine on serum corticosterone levels in rats.
    Zacny E; Bugajski J
    Horm Res; 1984; 20(2):116-23. PubMed ID: 6092253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intracerebroventricular clonidine on the hypothalamic noradrenaline and plasma corticosterone levels of opiate naive rats and after naloxone-induced withdrawal.
    Gonzalvez ML; Milanés MV; Martinez-Piñero MG; Marín MT; Vargas ML
    Brain Res; 1994 Jun; 647(2):199-203. PubMed ID: 7922496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.